Five-step clinical assessment in spastic paresis.

Jean‐Michel Graciès(Université Paris-Est Créteil), C. Colas, Salem A. Alkandari, Phuong T. Vu(Georgia Institute of Technology), Maria Vinti, Nicolas Bayle, C.-M. Loche

PubMed

September 1, 2010

Cited by 113

Related Papers

Pathophysiology of spastic paresis. II: Emergence of muscle overactivity

|Muscle & Nerve|2005|499

Short-term effects of dynamic Lycra splints on upper limb in hemiplegic patients

|Archives of Physical Medicine and Rehabilitation|2000|262

Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial

|The Lancet Neurology|2015|213

Traditional pharmacological treatments for spasticity part II: General and regional treatments

|Muscle & Nerve|1997|210

Botulinum Toxin Dilution and Endplate Targeting in Spasticity: A Double-Blind Controlled Study

|Archives of Physical Medicine and Rehabilitation|2009|185